Award
NIH Reporter #1F31DA067103-01
Emerging Synthetic Opioids and 92-agonists: Translational Investigation of Respiratory and Behavioral Risk
Recipient
Virginia Commonwealth University, Richmond, VA
Award Amount
$43,686.00
Ceiling
$43,686.00
Awarded
July 16, 2026
Identifier
1F31DA067103-01
The award supports research on the risks of synthetic opioids and 92-agonists, focusing on respiratory depression and behavioral effects to guide harm-reduction and public health interventions.
Description
This project investigates the respiratory and behavioral risks associated with emerging synthetic opioids, including the nitazene class, and 92-adrenergic agonists such as medetomidine. It aims to evaluate reinforcing effects, respiratory effects, and awareness among people who use opioids to inform harm-reduction strategies and public health messaging.